Recent Articles
After Last Week’s Surge, Just Say No to Hexo
The odds of U.S. marijuana legalization may have improved, but investors should stay away from struggling pot play HEXO stock.
Understand CIIG Merger Stock So We Know What SPAC to Buy
CIIC stock has been trading pretty well, but will likely come down with other SPACs eventually. Let's keep an eye on this one for the dip.
Koss Shares Still Have a Lot Further to Fall
KOSS stock got caught up in the recent trading frenzy, but is already fading. With fair value likely below $5, the plunge should continue.
Despite Huge Run, There’s Still Some Upside for Novavax
Though RNA vaccines may have jumped to the lead, the complexities of the Covid-19 crisis gives NVAX stock some extra room to run even higher.
Hims & Hers Stock Sits Where This Market Is Headed
Telehealth is the future, and Hims & Hers looks well-positioned for that future. Growth should keep the rally in HIMS stock going.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
